Depressive symptoms and CSF Alzheimer's disease biomarkers in relation to clinical symptom onset of mild cognitive impairment

INTRODUCTION: We sought to examine whether depressive symptoms and level of Alzheimer's disease (AD) pathology are independently or interactively associated with the risk of progression to mild cognitive impairment (MCI). METHODS: The study included a total of 216 participants from the Biomarke...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Carol K., Soldan, Anja, Pettigrew, Corinne, Wang, Jiangxia, Albert, Marilyn, Rosenberg, Paul B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Cerebrospinal Fluid Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513625/
https://www.ncbi.nlm.nih.gov/pubmed/33005725
http://dx.doi.org/10.1002/dad2.12106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513625/
https://www.ncbi.nlm.nih.gov/pubmed/33005725
http://dx.doi.org/10.1002/dad2.12106

Ejemplares similares